Joint Pain Injections Market Synopsis:
Joint Pain Injections Market Size Was Valued at USD 5.25 Billion in 2023, and is Projected to Reach USD 12.71 Billion by 2032, Growing at a CAGR of 10.4% From 2024-2032.
Joint pain injections market can be defined as the industry that deals in manufacturing and marketing of medications administered through injections to treat arthritis and other forms of joint pain. The most common type of injection that is given for arthritis is used for osteoarthritis, rheumatoid arthritis, and all other degenerative joint diseases. They are involved in inflammation reduction, pain elimination and increase joint mobility. These include corticosteroids and any injections that contain hyaluronic acid as well as platelet-rich plasma (PRP) injections given by healthcare professionals as a long and short-term treatment to patients experiencing joint pain.
The market of joint pain injections has been rising dramatically in the recent past due the rise in cases of Joint disorders like the Osteoarthritis and the rheumatoid arthritis especially in the elderly population. So luckily the aging population in the western countries is matched with the number of patients suffering from chronic joint pain and therefore, a demand for this solution. Another factor that the clinical workforce prefers injection and forms a part of modality is the increase in scale of key hole surgeries, which adds to the preference of the community for injections instead of surgery. These injections also afford quicker recoveries and minimize adverse effects linked to operations, which makes them popular with the patient and the medical profession alike.
In addition, with the enhancing technology in the field of biotechnology and increased focus towards regenerative medicine the variety of injectables present in the market has also increased. There are various family procedures that are getting popular, with possibilities to enhance healing and stimulate tissues’ regeneration, such as PRP injections. Market is also driven by higher awareness about the treatment and availability of ways in the emerging market where healthcare is also developing. Such a broad patient population along with constant advancements in injection therapeutic interventions has most assuredly contributed towards the emergence of a highly oligopolistic market.
.webp)
Joint Pain Injections Market Trend Analysis:
Increasing Adoption of Hyaluronic Acid Injections
-
Another which is apparent in the joint pain injections market is the rising demand for hyaluronic acid injected therapies. OA is one of the ailments that hyaluronic acid, a wrinkle that is natural to the human connective tissues, has been rising as a viable cure to joint pain. It assists in lubrication of the joint, increases the range of motion and eases pain, and hence are preferred where the patient is non-responsive to tablets or exercises. The uptake of the hyaluronic acid-based therapy is also increasing because of the increased client base seeking ant corticosteroid-based treatments that causes side effects such as cartilage erosion. Thus, the use of hyaluronic acid has been practiced and confirmed to have very minimal side effects compared to other drugs used in treating joint pain and it is fast becoming the new faces in the market.
Growing Demand in Emerging Markets
-
It is important for the joint pain injections market to note the emergence markets as great opportunities. This is due to improved awareness regarding the condition’s treatment together with modifications in lifestyle such as increased percentage of seniors and obesity in Asia-Pacific countries; Latin America; and some parts of the Middle East. About healthcare, these regions are also witnessing enhancement in further health care facilities along with access to sophisticated treatments. The perpetual increase in the disposable income in these countries mean more patients can afford expensive injection therapies than the traditional ones. Further, most of the multinationals in the healthcare sector are also increasing their investment in these regions as they continue to penetrate these markets with newer and more advanced products to meet the existing but unmet demands. The escalating health care costs within these economies are also anticipated to aide market growth in the future years.
Joint Pain Injections Market Segment Analysis:
Joint Pain Injections Market is Segmented on the basis of Product, Joint Type, End User, and Region
By Type, Corticosteroid Injections segment is expected to dominate the market during the forecast period
-
Based on type, Corticosteroid Injections segment expected to generate the highest revenue during the forecast period for Joint Pain Injections market. This dominance is mostly since corticosteroids, which are widely prescribed drugs, provide fast alleviation of patients’ pain when they suffer from different joint disorders, including osteoarthritis and rheumatoid arthritis. Corticosteroid injections have long been in clinical use because of the convenience they provide in pain management and tend to be the first interventional therapy when oral anti-inflammatory drugs are not effective in treating joint pain. They are also less expensive than many of the newer treatments including biologic or hyaluronic acid filler treatments making them choice to many health care systems across the world. Investor demand is expected to remain strong because joint-related conditions are becoming increasingly common, and corticosteroid injections will remain the dominant segment.
By Joint Type, Knee segment expected to held the largest share
-
By joint type, the Knee segment is anticipated to dominate the joint pain injections market in the years to come. This is because one of the most widespread knee issues as well as a cause of joint pain is osteoarthritis, which has become increasingly more frequent today. Knee joint issue is caused by ageing, obesity, and physical activities as these make the knee joint to wear out faster and therefore there is a need to have treatments that will enable the people with knee issues to have relief hence can have an improved mobility. Some of the knee injections include corticosteroids, hyaluronic acid injections, and platelet-rich plasma injection to reduce pain in patients experiencing osteoarthritis in the knee area making this segment important. Furthermore, the increasing elderly people’s group and increasing consciousness of the non-operative treatment approach are the key factors that will propel knee joint injections segment, which holds the largest share in the market.
Joint Pain Injections Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America held the largest share in the joint pain injections market in 2023. The region has a strong healthcare system, more incidences of joint related disorders and a rising need for better treatments. In the United States, increasing number of join pain injections is highly attributed by the growing number of baby boomers, and the rising prevalence of obesity. Other factors that have enhanced the status of North America in this market include high tech availability alongside focus on research and development. The latest study reveals that North America commanded nearly 45% of the joint pain injections market in 2023.
Active Key Players in the Joint Pain Injections Market:
-
Anika Therapeutics, Inc. (United States)
- Bioventus LLC (United States)
- Chugai Pharmaceutical Co., Ltd. (Japan)
- Ferring Pharmaceuticals (Switzerland)
- Flexion Therapeutics, Inc. (United States)
- Johnson & Johnson (United States)
- LG Chem (South Korea)
- OrthogenRx, Inc. (United States)
- Pfizer Inc. (United States)
- Sanofi S.A. (France)
- Seikagaku Corporation (Japan)
- Smith & Nephew plc (United Kingdom)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Virbac (France)
- Zimmer Biomet (United States)
- Other Active Players
Key Industry Developments in the Joint Pain Injections Market:
-
December 2019, The Supplemental New Drug Application to amend the ZILRETTA product label and provide more precise information about the medicine was approved by the U.S. FDA, according to Flexion Therapeutics Inc.
|
Joint Pain Injections Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 5.25 Billion |
|
Forecast Period 2024-32 CAGR: |
10.4% |
Market Size in 2032: |
USD 12.71 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Joint Type |
|
||
|
End Users |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Joint Pain Injections Market by Product
4.1 Joint Pain Injections Market Snapshot and Growth Engine
4.2 Joint Pain Injections Market Overview
4.3 Corticosteroid Injections
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Corticosteroid Injections: Geographic Segmentation Analysis
4.4 Hyaluronic Acid Injections
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Hyaluronic Acid Injections: Geographic Segmentation Analysis
4.5 Platelet Rich Plasma Injections
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Platelet Rich Plasma Injections: Geographic Segmentation Analysis
4.6 and Others
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 and Others: Geographic Segmentation Analysis
Chapter 5: Joint Pain Injections Market by Joint Type
5.1 Joint Pain Injections Market Snapshot and Growth Engine
5.2 Joint Pain Injections Market Overview
5.3 Knee
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Knee: Geographic Segmentation Analysis
5.4 Hip
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hip: Geographic Segmentation Analysis
5.5 Hand & Wrist
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Hand & Wrist: Geographic Segmentation Analysis
5.6 and Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 and Others: Geographic Segmentation Analysis
Chapter 6: Joint Pain Injections Market by End User
6.1 Joint Pain Injections Market Snapshot and Growth Engine
6.2 Joint Pain Injections Market Overview
6.3 Hospital Pharmacies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Pharmacies: Geographic Segmentation Analysis
6.4 Retail Pharmacies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Retail Pharmacies: Geographic Segmentation Analysis
6.5 and Online Pharmacies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 and Online Pharmacies: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Joint Pain Injections Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ANIKA THERAPEUTICS INC. (UNITED STATES)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BIOVENTUS LLC (UNITED STATES)
7.4 CHUGAI PHARMACEUTICAL CO. LTD. (JAPAN)
7.5 FERRING PHARMACEUTICALS (SWITZERLAND)
7.6 FLEXION THERAPEUTICS INC. (UNITED STATES)
7.7 JOHNSON & JOHNSON (UNITED STATES)
7.8 LG CHEM (SOUTH KOREA)
7.9 ORTHOGENRX INC. (UNITED STATES)
7.10 PFIZER INC. (UNITED STATES)
7.11 SANOFI S.A. (FRANCE)
7.12 SEIKAGAKU CORPORATION (JAPAN)
7.13 SMITH & NEPHEW PLC (UNITED KINGDOM)
7.14 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.15 VIRBAC (FRANCE)
7.16 ZIMMER BIOMET (UNITED STATES)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Joint Pain Injections Market By Region
8.1 Overview
8.2. North America Joint Pain Injections Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product
8.2.4.1 Corticosteroid Injections
8.2.4.2 Hyaluronic Acid Injections
8.2.4.3 Platelet Rich Plasma Injections
8.2.4.4 and Others
8.2.5 Historic and Forecasted Market Size By Joint Type
8.2.5.1 Knee
8.2.5.2 Hip
8.2.5.3 Hand & Wrist
8.2.5.4 and Others
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospital Pharmacies
8.2.6.2 Retail Pharmacies
8.2.6.3 and Online Pharmacies
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Joint Pain Injections Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product
8.3.4.1 Corticosteroid Injections
8.3.4.2 Hyaluronic Acid Injections
8.3.4.3 Platelet Rich Plasma Injections
8.3.4.4 and Others
8.3.5 Historic and Forecasted Market Size By Joint Type
8.3.5.1 Knee
8.3.5.2 Hip
8.3.5.3 Hand & Wrist
8.3.5.4 and Others
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospital Pharmacies
8.3.6.2 Retail Pharmacies
8.3.6.3 and Online Pharmacies
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Joint Pain Injections Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product
8.4.4.1 Corticosteroid Injections
8.4.4.2 Hyaluronic Acid Injections
8.4.4.3 Platelet Rich Plasma Injections
8.4.4.4 and Others
8.4.5 Historic and Forecasted Market Size By Joint Type
8.4.5.1 Knee
8.4.5.2 Hip
8.4.5.3 Hand & Wrist
8.4.5.4 and Others
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospital Pharmacies
8.4.6.2 Retail Pharmacies
8.4.6.3 and Online Pharmacies
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Joint Pain Injections Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product
8.5.4.1 Corticosteroid Injections
8.5.4.2 Hyaluronic Acid Injections
8.5.4.3 Platelet Rich Plasma Injections
8.5.4.4 and Others
8.5.5 Historic and Forecasted Market Size By Joint Type
8.5.5.1 Knee
8.5.5.2 Hip
8.5.5.3 Hand & Wrist
8.5.5.4 and Others
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospital Pharmacies
8.5.6.2 Retail Pharmacies
8.5.6.3 and Online Pharmacies
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Joint Pain Injections Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product
8.6.4.1 Corticosteroid Injections
8.6.4.2 Hyaluronic Acid Injections
8.6.4.3 Platelet Rich Plasma Injections
8.6.4.4 and Others
8.6.5 Historic and Forecasted Market Size By Joint Type
8.6.5.1 Knee
8.6.5.2 Hip
8.6.5.3 Hand & Wrist
8.6.5.4 and Others
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospital Pharmacies
8.6.6.2 Retail Pharmacies
8.6.6.3 and Online Pharmacies
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Joint Pain Injections Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product
8.7.4.1 Corticosteroid Injections
8.7.4.2 Hyaluronic Acid Injections
8.7.4.3 Platelet Rich Plasma Injections
8.7.4.4 and Others
8.7.5 Historic and Forecasted Market Size By Joint Type
8.7.5.1 Knee
8.7.5.2 Hip
8.7.5.3 Hand & Wrist
8.7.5.4 and Others
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospital Pharmacies
8.7.6.2 Retail Pharmacies
8.7.6.3 and Online Pharmacies
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Joint Pain Injections Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 5.25 Billion |
|
Forecast Period 2024-32 CAGR: |
10.4% |
Market Size in 2032: |
USD 12.71 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Joint Type |
|
||
|
End Users |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
